COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Scott Weiner to join panel at 2nd Annual Global Healthcare Investing Conference
News | 04. 30. 2008
